Evoke Pharma Inc. Daily Stock Analysis

Daily Stock Analysis, EVOK, Evoke Pharma Inc, priceseries

Evoke Pharma Inc. Daily Stock Analysis
Stock Information
Open
0.59
Close
0.60
High
0.61
Low
0.59
Previous Close
0.60
Daily Price Gain
0.00
YTD High
0.69
YTD High Date
Feb 15, 2022
YTD Low
0.47
YTD Low Date
Jan 25, 2022
YTD Price Change
0.01
YTD Gain
1.35%
52 Week High
3.20
52 Week High Date
Mar 11, 2021
52 Week Low
0.47
52 Week Low Date
Jan 25, 2022
52 Week Price Change
-2.18
52 Week Gain
-78.42%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jan 3. 2017
2.07
Jan 11. 2017
2.44
6 Trading Days
17.71%
Link
LONG
Sep 1. 2017
2.60
Sep 26. 2017
3.18
16 Trading Days
22.46%
Link
LONG
Apr 11. 2018
2.20
Apr 23. 2018
2.35
8 Trading Days
6.91%
Link
LONG
May 4. 2018
2.51
May 25. 2018
2.90
15 Trading Days
15.58%
Link
LONG
Aug 28. 2018
2.60
Sep 19. 2018
3.20
15 Trading Days
23.03%
Link
LONG
Dec 28. 2018
2.30
Jan 16. 2019
2.52
12 Trading Days
9.78%
Link
LONG
Jul 3. 2019
0.66
Jul 25. 2019
1.07
15 Trading Days
62.71%
Link
LONG
Nov 12. 2019
0.92
Dec 12. 2019
1.61
21 Trading Days
74.93%
Link
LONG
Apr 8. 2020
1.08
Apr 22. 2020
1.19
9 Trading Days
9.85%
Link
LONG
May 15. 2020
1.47
Jun 4. 2020
2.20
13 Trading Days
49.91%
Link
LONG
Jul 30. 2020
3.67
Aug 21. 2020
5.06
16 Trading Days
37.87%
Link
LONG
Feb 3. 2021
2.87
Feb 18. 2021
3.46
10 Trading Days
20.43%
Link
Company Information
Stock Symbol
EVOK
Exchange
NasdaqCM
Company URL
http://www.evokepharma.com
Company Phone
858-345-1494
CEO
David A. Gonyer
Headquarters
California
Business Address
420 STEVENS AVENUE, SUITE 370, SOLANA BEACH, CA 92075
Sector
Equity
Industry Category
Drugs
Industry Group
Drugs - Generic
CIK
0001403708
About

Evoke Pharma, Inc. is a pharmaceutical company, which engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. It develops EVK-001 for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. The company was founded by Matthew J. D'Onofrio, Cam L. Garner, Scott L. Glenn and David A. Gonyer on January 29, 2007 and is headquartered in Solana Beach, CA.

Description

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development of drugs for the treatment of gastroenterological disorders and diseases. The company develops EVK-001, a metoclopramide nasal spray, which is in Phase III clinical trials for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Evoke Pharma, Inc. was founded in 2007 and is headquartered in Solana Beach, California.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading